|Videos|May 18, 2023
Updates in the Treatment of Advanced/Recurrent Endometrial Cancer: Data from the NRG-GY018 Study
Ramez Eskander, MD, presents data from the GY018 study investigating pembrolizumab versus placebo in addition to carboplatin/paclitaxel in patients with advanced/recurrent endometrial cancer.
Advertisement
Episodes in this series
Advertisement
Related to this article
Beth Erickson, MD, FACR, FASTRO, FABS, discussed pioneering MRI-guided brachytherapy at MCW and her priorities as incoming ASTRO president-elect.
Advertisement
Advertisement
Trending on CancerNetwork
1
The Case for Frontline Zongertinib in HER2-Mutant NSCLC
2
Isatuximab-Based Therapy Shows “Impressive” PFS Projections in NDMM
3
Durvalumab Plus Enfortumab Vedotin Earns FDA Priority Review in MIBC
4
Emerging Endocrine Doublets and Serial ESR1 Testing in HR+/HER2− mBC
5